Vimarsana
Biggest News Aggregation in the World

Page 4 - Evofem Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evofem Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evofem Bioscience Today - Breaking & Trending Today

Evofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act - Vimarsana News

Evofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act

/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM), a women's healthcare company, today applauded the 228 members of the U.S. House of Representatives...

Phexxi® Mechanism of Action Article Published in the Journal of Therapeutic Advances in Reproductive Health - Vimarsana News

Phexxi® Mechanism of Action Article Published in the Journal of Therapeutic Advances in Reproductive Health

/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) announced today that the Journal of Therapeutic Advances in Reproductive Health has published...

Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO - Vimarsana News

Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO

/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) announced today that the United States Patent and Trademark Office (USPTO) issued to the Company a...

Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi® - Vimarsana News

Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi®

/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has reached an agreement with one of the nation's largest pharmacy benefit managers...

Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data - Vimarsana News

Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data

/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced results of a post hoc analysis of the registrational Phase 3 AMPOWER trial...